These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11867363)
1. Rapacuronium and the risk of bronchospasm in pediatric patients. Rajchert DM; Pasquariello CA; Watcha MF; Schreiner MS Anesth Analg; 2002 Mar; 94(3):488-93; table of contents. PubMed ID: 11867363 [TBL] [Abstract][Full Text] [Related]
2. Bronchospasm after rapacuronium in infants and children. Meakin GH; Pronske EH; Lerman J; Orr R; Joffe D; Savaree AM; Lynn AM Anesthesiology; 2001 May; 94(5):926-7. PubMed ID: 11388548 [No Abstract] [Full Text] [Related]
3. Rapacuronium and bronchospasm. Goudsouzian NG Anesthesiology; 2001 May; 94(5):727-8. PubMed ID: 11388519 [No Abstract] [Full Text] [Related]
4. Severe bronchospasm and desaturation in a child associated with rapacuronium. Kron SS Anesthesiology; 2001 May; 94(5):923-4. PubMed ID: 11388546 [No Abstract] [Full Text] [Related]
5. The effect on lung mechanics in anesthetized children with rapacuronium: a comparative study with mivacurium. Fine GF; Motoyama EK; Brandom BW; Fertal KM; Mutich R; Davis PJ Anesth Analg; 2002 Jul; 95(1):56-61, table of contents. PubMed ID: 12088943 [TBL] [Abstract][Full Text] [Related]
6. How serious is the bronchospasm induced by rapacuronium? Naguib M Anesthesiology; 2001 May; 94(5):924-5. PubMed ID: 11388547 [No Abstract] [Full Text] [Related]
7. Another possible mechanism for bronchospasm after rapacuronium. Stuth EA; Stucke AG; Setlock MA Anesthesiology; 2002 Jun; 96(6):1528-9. PubMed ID: 12170075 [No Abstract] [Full Text] [Related]
10. A dose-ranging study of rapacuronium in pediatric patients. Meakin GH; Meretoja OA; Motsch J; Taivainen T; Wirtavuori K; Schönstedt R; Perkins R; McCluskey A Anesthesiology; 2000 Apr; 92(4):1002-9. PubMed ID: 10754619 [TBL] [Abstract][Full Text] [Related]
11. Newer neuromuscular blocking agents: how do they compare with established agents? Sparr HJ; Beaufort TM; Fuchs-Buder T Drugs; 2001; 61(7):919-42. PubMed ID: 11434449 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent. Larijani GE; Zafeiridis A; Goldberg ME Pharmacotherapy; 1999 Oct; 19(10):1118-22. PubMed ID: 10512060 [TBL] [Abstract][Full Text] [Related]
14. Rapacuronium bromide: a review of its use in anaesthetic practice. Onrust SV; Foster RH Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867 [TBL] [Abstract][Full Text] [Related]
15. Rapacuronium: why did it fail as a replacement for succinylcholine? White PF Br J Anaesth; 2002 Feb; 88(2):163-5. PubMed ID: 11878650 [No Abstract] [Full Text] [Related]
16. Intramuscular rapacuronium in infants and children: a comparative multicenter study to confirm the efficacy and safety of the age-related tracheal intubating doses of intramuscular rapacuronium (ORG 9487) in two groups of pediatric subjects. Denman WT; Kaplan RF; Goudsouzian NG; Uejima T; Barcelona SL; Cote CJ; Ginsberg B; Hannallah RS Anesthesiology; 2001 Jan; 94(1):3-7. PubMed ID: 11135715 [TBL] [Abstract][Full Text] [Related]
17. Rapacuronium: premarket drug evaluation can be very effective for the identification of drug risks. Lim R Anesth Analg; 2003 Feb; 96(2):631-2. PubMed ID: 12538231 [No Abstract] [Full Text] [Related]
18. The potency (ED50) and cardiovascular effects of rapacuronium (Org 9487) during narcotic-nitrous oxide-propofol anesthesia in neonates, infants, and children. Kaplan RF; Fletcher JE; Hannallah RS; Bui DT; Slaven JS; Darrow EJ; Tsai KT Anesth Analg; 1999 Nov; 89(5):1172-6. PubMed ID: 10553829 [TBL] [Abstract][Full Text] [Related]